Glibenclamide/OZ-101

N/A

Report date: 2022/03/22 11:18:40

Base Information

Drug NameGlibenclamide/OZ-101
Drug Alias NameOZ-101/Glibenclamide
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersSulfonylurea receptor 1 inhibitors
TargetsPotassium channelSulfonylurea receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes GlibenclamideOZ-101
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesOzstar Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOzstar Therapeutics
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A